BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23091899)

  • 1. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and ovarian cancer risk in Polish women.
    Romanowicz-Makowska H; Smolarz B; Samulak D; Michalska M; Lewy J; Burzyński M; Kokołaszwili G
    Eur J Gynaecol Oncol; 2012; 33(4):406-10. PubMed ID: 23091899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
    Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
    Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between polymorphisms of the DNA repair gene RAD51 and ovarian cancer.
    Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Romanowicz H; Wilczak M
    Pol J Pathol; 2013 Dec; 64(4):290-5. PubMed ID: 24375044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
    Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
    Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women.
    Smolarz B; Zadrożny M; Duda-Szymańska J; Makowska M; Samulak D; Michalska MM; Mojs E; Bryś M; Forma E; Romanowicz-Makowska H
    Pol J Pathol; 2013 Apr; 64(1):39-43. PubMed ID: 23625599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.
    Michalska MM; Samulak D; Romanowicz H; Smolarz B
    Pathol Oncol Res; 2015 Sep; 21(4):935-40. PubMed ID: 25743260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD51 gene polymorphisms and sporadic colorectal cancer risk in Poland.
    Romanowicz-Makowska H; Samulak D; Michalska M; Sporny S; Langner E; Dziki A; Sychowski R; Smolarz B
    Pol J Pathol; 2012 Nov; 63(3):193-8. PubMed ID: 23161237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women.
    Romanowicz-Makowska H; Smolarz B; Połać I; Sporny S
    J Obstet Gynaecol Res; 2012 Jun; 38(6):918-24. PubMed ID: 22487057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
    Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
    Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms in the 5' untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population.
    Michalska MM; Samulak D; Romanowicz H; Smolarz B
    Arch Gynecol Obstet; 2014 Nov; 290(5):985-91. PubMed ID: 24930116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the G/C polymorphism in the 5'-untranslated region of the RAD51 gene in breast cancer.
    Blasiak J; Przybyłowska K; Czechowska A; Zadrozny M; Pertyński T; Rykała J; Kołacińska A; Morawiec Z; Drzewoski J
    Acta Biochim Pol; 2003; 50(1):249-53. PubMed ID: 12673366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.
    Gao LB; Pan XM; Li LJ; Liang WB; Zhu Y; Zhang LS; Wei YG; Tang M; Zhang L
    Breast Cancer Res Treat; 2011 Feb; 125(3):827-35. PubMed ID: 20640595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism RAD51 172G > T in Serbian patients with colorectal cancer.
    Petrovic-Sunderic J; Dragicevic S; Krnjajic M; Ristanovic M; Nikolic A; Krivokapic Z
    J BUON; 2018; 23(4):936-940. PubMed ID: 30358196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.
    Wang Z; Dong H; Fu Y; Ding H
    Breast Cancer Res Treat; 2010 Dec; 124(3):765-9. PubMed ID: 20396943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer.
    Smolarz B; Michalska MM; Samulak D; Romanowicz H; Wójcik L
    Pathol Oncol Res; 2019 Oct; 25(4):1607-1614. PubMed ID: 30712190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland.
    Romanowicz-Makowska H; Smolarz B; Zadrozny M; Westfa B; Baszczyński J; Kokołaszwili G; Burzyfiski M; Połać I; Sporny S
    Eur J Gynaecol Oncol; 2012; 33(2):145-50. PubMed ID: 22611952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.
    Cheng D; Shi H; Zhang K; Yi L; Zhen G
    Diagn Pathol; 2014 Jan; 9():18. PubMed ID: 24457040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.
    Zeng X; Zhang Y; Yang L; Xu H; Zhang T; An R; Zhu K
    Medicine (Baltimore); 2018 Jun; 97(26):e11251. PubMed ID: 29952992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between RAD51, XRCC2 and XRCC3 gene polymorphisms and risk of ovarian cancer: a case control and an in silico study.
    Gowtham Kumar G; Paul SFD; Martin J; Manickavasagam M; Sundersingh S; Ganesan N; Ramya R; Usha Rani G; Andrea Mary F
    Mol Biol Rep; 2021 May; 48(5):4209-4220. PubMed ID: 34097201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.
    Antoniou AC; Sinilnikova OM; Simard J; Léoné M; Dumont M; Neuhausen SL; Struewing JP; Stoppa-Lyonnet D; Barjhoux L; Hughes DJ; Coupier I; Belotti M; Lasset C; Bonadona V; Bignon YJ; ; Rebbeck TR; Wagner T; Lynch HT; Domchek SM; Nathanson KL; Garber JE; Weitzel J; Narod SA; Tomlinson G; Olopade OI; Godwin A; Isaacs C; Jakubowska A; Lubinski J; Gronwald J; Górski B; Byrski T; Huzarski T; Peock S; Cook M; Baynes C; Murray A; Rogers M; Daly PA; Dorkins H; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Niederacher D; Deissler H; ; Spurdle AB; Chen X; Waddell N; Cloonan N; ; Kirchhoff T; Offit K; Friedman E; Kaufmann B; Laitman Y; Galore G; Rennert G; Lejbkowicz F; Raskin L; Andrulis IL; Ilyushik E; Ozcelik H; Devilee P; Vreeswijk MP; Greene MH; Prindiville SA; Osorio A; Benitez J; Zikan M; Szabo CI; Kilpivaara O; Nevanlinna H; Hamann U; Durocher F; Arason A; Couch FJ; Easton DF; Chenevix-Trench G;
    Am J Hum Genet; 2007 Dec; 81(6):1186-200. PubMed ID: 17999359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.